A Randomized Phase 1 Dose Escalation Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Trabodenoson in Healthy Adult Volunteers

por Laties, Alan, Rich, Cadmus C., Stoltz, Randall, Humbert, Vernon, Brickman, Chaim, McVicar, William, Baumgartner, Rudolf A.
Publicado 2016

Topical Trabodenoson Is Neuroprotective in a Rodent Model of Anterior Ischemic Optic Neuropathy (rNAION)

por Guo, Yan, Mehrabian, Zara, Johnson, Mary A., Albers, David S., Rich, Cadmus C., Baumgartner, Rudolf A., Bernstein, Steven L.
Publicado 2019

A Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of 2 and 4 Weeks of Twice-Daily Ocular Trabodenoson in Adults with Ocular Hypertension...

por Myers, Jonathan S., Sall, Kenneth N., DuBiner, Harvey, Slomowitz, Natanya, McVicar, William, Rich, Cadmus C., Baumgartner, Rudolf A.
Publicado 2016

Trabodenoson, an Adenosine Mimetic With A(1) Receptor Selectivity Lowers Intraocular Pressure by Increasing Conventional Outflow Facility in Mice

por Li, Guorong, Torrejon, Karen Y., Unser, Andrea M., Ahmed, Feryan, Navarro, Iris D., Baumgartner, Rudolf A., Albers, David S., Stamer, W. Daniel
Publicado 2018